Notice to Readers Haemophilus influenzae Type b Vaccine
On December 22, 1987, the U.S. Food and Drug Administration
licensed a new Haemophilus influenzae type b (Hib) vaccine for use
in
children 18 months of age and older. The manufacturer is expected
to
begin distribution of the Hib polysaccharide- diphtheria conjugate
vaccine within a few weeks. The Immunization Practices Advisory
Committee (ACIP) recommendations for use of the vaccine will be
published soon in the MMWR.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to [email protected].
